LDC1P

Across TCGA pan-cancer cohorts, LDC1P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LDC1P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LDC1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LDC1P expression acts as an unfavorable survival marker, although some lineages such as SKCM and PAAD show a favorable association.

KIRC, ACC, and LIHC are the cancer types where LDC1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.524	0.723	.004	52	view →
ACC	OS	Tertile	II,III,IV	0.597	0.917	.011	33	view →
LIHC	OS	Quartile	All	0.652	0.818	.003	32	view →
SKCM	OS	Median	III,IV	0.579	0.320	.004	31	view →
LGG	DFS	Tertile	All	0.224	0.430	.003	24	view →
PAAD	DFS	Median	II,III,IV	0.483	0.267	.005	21	view →
THYM	OS	Median	All	1.000	0.738	.001	19	view →
HNSC	OS	Median	All	0.455	0.283	.017	13	view →
ESCA	DFS	Median	All	0.441	0.827	.021	12	view →
READ	DFS	Median	IV	0.396	0.761	.013	9	view →
CESC	DFS	Tertile	II,III,IV	0.852	0.664	.017	8	view →
LAML	DFS	Median	All	0.262	0.503	.035	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LDC1P–KIRC (DFS)

Open the KIRC breakdown →